Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Genpharmasec Limited

Market Cap 432M 4.54M 3.92M 3.62M 3.39M 6.35M 6.45M 42.86M 16.67M 210M 17.04M 16.68M 728M P/E Ratio 2024
-545x
P/E Ratio 2025 94.5x
Enterprise Value 422M 4.44M 3.84M 3.54M 3.31M 6.22M 6.31M 41.92M 16.31M 206M 16.67M 16.32M 712M EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
55.34%
Yield 2024 *
-
Yield 2025 -
1 week+0.88%
Current month-4.20%
1 month-4.20%
3 months+10.68%
6 months-17.39%
Current year-12.98%
1 week 1.09
Extreme 1.09
1.2
1 month 1.09
Extreme 1.09
1.34
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.2
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
12.4
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 38 2022-10-31
Compliance Officer - 2024-03-26
Director TitleAgeSince
Director/Board Member 57 2019-01-01
Director/Board Member 58 2019-01-01
Director/Board Member - 2022-10-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.88%-48.18%-70.39% 6.64M
-1.64%-3.17%-35.38%-13.04% 154B
-0.16%-1.80%-9.37%-4.84% 103B
+0.07%+2.41%-4.53%+57.08% 54.8B
+3.00%+0.30%+55.27%+51.53% 55.22B
-0.75%-3.25%-16.18%-41.67% 40.3B
-1.40%+8.93% - - 30.96B
+0.16%+3.44%-9.03%-40.61% 29.08B
-0.46%+4.55%+46.20%-7.99% 23.23B
-2.85%-3.53%-16.97%-1.50% 20.25B
Average -0.40%+1.00%-4.24%-7.94% 51.04B
Weighted average by Cap. -0.46%-0.31%-7.88%+0.83%

Financials

2024 2025
Net sales 304M 3.2M 2.76M 2.55M 2.39M 4.47M 4.54M 30.17M 11.74M 148M 12M 11.74M 512M 337M 3.55M 3.06M 2.82M 2.65M 4.96M 5.03M 33.46M 13.02M 164M 13.31M 13.02M 568M
Net income -1.26M -13.22K -11.42K -10.53K -9.86K -18.49K -18.77K -125K -48.53K -611K -49.6K -48.55K -2.12M 12.31M 129K 112K 103K 96.58K 181K 184K 1.22M 475K 5.99M 486K 475K 20.75M
Net Debt -179M -1.88M -1.63M -1.5M -1.4M -2.63M -2.67M -17.75M -6.91M -87M -7.06M -6.91M -301M -9.4M -98.87K -85.45K -78.74K -73.76K -138K -140K -933K -363K -4.57M -371K -363K -15.85M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
26-06-12 1.140 0.00% 314,097
26-06-11 1.140 0.00% 143,833
26-06-10 1.140 +2.70% 380,398
26-06-09 1.110 0.00% 718,590
26-06-08 1.110 -1.77% 277,605
  1. Stock Market
  2. Stocks
  3. 531592 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!